Calyxt, Inc. (CLXT)
| Market Cap | 208.68M |
| Revenue (ttm) | 13.69M |
| Net Income (ttm) | -43.61M |
| Shares Out | 33.20M |
| EPS (ttm) | -1.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $6.07 |
| Previous Close | $5.04 |
| Change ($) | 1.03 |
| Change (%) | 20.34% |
| Day's Open | 5.16 |
| Day's Range | 5.12 - 6.19 |
| Day's Volume | 708,317 |
| 52-Week Range | 2.48 - 7.65 |
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soy...
Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies.
Calyxt (CLXT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene's c...
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the third quarter ended September 30, 2020. Execution o...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW), a...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The V...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the closing of its previously announced registered direct offe...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced that it has entered into definitive agreements with institutio...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss...
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.
Calyxt, Inc. (CLXT) CEO James Blome on Q2 2020 Results - Earnings Call Transcript
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appoi...
U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.
Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Calyxt's (CLXT) CEO Jim Blome on Q1 2020 Results - Earnings Call Transcript
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q4 2019 Results - Earnings Call Transcript
Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.
Falling knives are companies whose share prices have declined more than 59% over the last 52 weeks.
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2019 Results - Earnings Call Transcript
Calyxt, Inc. (CLXT) CEO Jim Blome on Q2 2019 Results - Earnings Call Transcript
Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt has now commercialized two products from its high-oleic soybean platform and sales should start ramping this year.
Calyxt, Inc. (CLXT) CEO Jim Blome on Q1 2019 Results - Earnings Call Transcript
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Calyxt (CLXT) delivered earnings and revenue surprises of -4.00% and -99.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
About CLXT
Calyxt, a technology company, focuses on delivering plant-based solutions in the United States. The company offers high oleic soybean products, including oil and meal. It also develops high fiber wheat; improved digestibility alfalfa; and cold storable potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
| Industry Packaged Foods | IPO Date Jul 20, 2017 |
| CEO James A. Blome | Employees 75 |
| Stock Exchange NASDAQ | Ticker Symbol CLXT |
Financial Performance
In 2019, Calyxt's revenue was $7.30 million, an increase of 2,991.53% compared to the previous year's $236,000. Losses were -$39.61 million, 42.0% more than in 2018.
Analyst Forecasts
According to 7 analysts, the average rating for Calyxt stock is "Buy." The 12-month stock price forecast is 7.13, which is an increase of 17.56% from the latest price.